02268nam a2200421 a 4500003491552MiAaHDL20250726000000.0m d cr bn ---auaua000710s1996 dcu b f000 0 eng d(MiU)990034915520106381sdr-miu.990034915520106381(MiU)MIU01000000000000003491552-goog(OCoLC)35774983(MiU)Aleph003491552157507GAO (202) 512-6000 (Voice); (301) 258-4066 (Fax)GAOGAOEYMUtOrBLWn-us---GA 1.5/2:T-HEHS-96-216HD9666.4.J3317Jaggar, Sarah F.Prescription drug pricing :implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /United States General Accounting Office.Implications for retail pharmaciesWashington, D.C. :The Office ;Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) :The Office [distributor],[1996]8 p. :chart ;28 cm.texttxtrdacontentunmediatednrdamediavolumencrdacarrierTestimony ;GAO/T-HEHS-96-216"September 19, 1996."Cover title.Includes bibliographical references (p. 8).Mode of access: Internet.Drug Costs.http://id.nlm.nih.gov/mesh/D016527DrugstoresUnited States.DrugsPricesUnited States.http://id.loc.gov/authorities/subjects/sh2008102459Prescription pricingUnited States.http://id.loc.gov/authorities/subjects/sh2008109174United States.Congress.House.Committee on Commerce.Subcommittee on Oversight and Investigations.http://id.loc.gov/authorities/names/no95033770http://id.loc.gov/rwo/agents/no95033770United States.General Accounting Office.http://id.loc.gov/authorities/names/n80126064http://id.loc.gov/rwo/agents/n8012606439015048868817Buhr B 150845800349155220241217213721.020250726000000.020260304165331.02026-03-05T10:55:07Z2025-12-22T18:50:03ZSDR-MIUmiuALMAprepare.pl-004-009BKsdr-miu.990034915520106381MiUSDRMIU003491552mdp.39015048868817MIU990034915520106381MIUMIU20260305googlemdp.390150488688171996pdbibUS fed doc